ID   B2CL1_RAT               Reviewed;         233 AA.
AC   P53563; P70613; P70614; Q52KS0; Q62678; Q62836; Q64087; Q64128;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-OCT-2024, entry version 208.
DE   RecName: Full=Bcl-2-like protein 1;
DE            Short=Bcl2-L-1;
DE   AltName: Full=Apoptosis regulator Bcl-X;
GN   Name=Bcl2l1; Synonyms=Bclx, Blc2l;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS BCL-X(L) AND BCL-X(S)).
RC   TISSUE=Brain;
RA   Michaelidis T.M.;
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORM BCL-X(L)).
RC   TISSUE=Brain;
RA   Wesselingh S.L., David G.L., Choi S., Veliuona M., Hardwick J.M.;
RT   "Cloning and expression of rat bcl-x in cultured neurons.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BCL-X(L) AND BCL-X(BETA)), AND
RP   FUNCTION.
RC   TISSUE=Thymus;
RX   PubMed=8662675; DOI=10.1074/jbc.271.22.13258;
RA   Shiraiwa N., Inohara N., Okada S., Yuzaki M., Shoji S., Ohta S.;
RT   "An additional form of rat Bcl-x, Bcl-xbeta, generated by an unspliced RNA,
RT   promotes apoptosis in promyeloid cells.";
RL   J. Biol. Chem. 271:13258-13265(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS BCL-X(L) AND BCL-X(S)), AND FUNCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Ovary;
RX   PubMed=7828536; DOI=10.1210/endo.136.1.7828536;
RA   Tilly J.L., Tilly K.I., Kenton M.L., Johnson A.L.;
RT   "Expression of members of the Bcl-2 gene family in the immature rat ovary:
RT   equine chorionic gonadotropin-mediated inhibition of granulosa cell
RT   apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-
RT   xlong messenger ribonucleic acid levels.";
RL   Endocrinology 136:232-241(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BCL-X(L)).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN SYNAPTIC VESICLE REGULATION, AND INTERACTION WITH DNM1L.
RX   PubMed=18250306; DOI=10.1073/pnas.0711647105;
RA   Li H., Chen Y., Jones A.F., Sanger R.H., Collis L.P., Flannery R.,
RA   McNay E.C., Yu T., Schwarzenbacher R., Bossy B., Bossy-Wetzel E.,
RA   Bennett M.V., Pypaert M., Hickman J.A., Smith P.J., Hardwick J.M.,
RA   Jonas E.A.;
RT   "Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal
RT   neurons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2169-2174(2008).
RN   [7]
RP   FUNCTION IN SYNAPTIC VESICLE REGULATION, INTERACTION WITH ATP5F1A AND
RP   ATP5F1B, AND SUBCELLULAR LOCATION.
RX   PubMed=21926988; DOI=10.1038/ncb2330;
RA   Alavian K.N., Li H., Collis L., Bonanni L., Zeng L., Sacchetti S.,
RA   Lazrove E., Nabili P., Flaherty B., Graham M., Chen Y., Messerli S.M.,
RA   Mariggio M.A., Rahner C., McNay E., Shore G.C., Smith P.J., Hardwick J.M.,
RA   Jonas E.A.;
RT   "Bcl-xL regulates metabolic efficiency of neurons through interaction with
RT   the mitochondrial F1FO ATP synthase.";
RL   Nat. Cell Biol. 13:1224-1233(2011).
RN   [8]
RP   FUNCTION IN SYNAPTIC VESICLE REGULATION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH CLTA; DNM1L AND MFF.
RX   PubMed=23792689; DOI=10.1038/ncb2791;
RA   Li H., Alavian K.N., Lazrove E., Mehta N., Jones A., Zhang P.,
RA   Licznerski P., Graham M., Uo T., Guo J., Rahner C., Duman R.S.,
RA   Morrison R.S., Jonas E.A.;
RT   "A Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics during
RT   endocytosis.";
RL   Nat. Cell Biol. 15:773-785(2013).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=9346936; DOI=10.1074/jbc.272.44.27886;
RA   Aritomi M., Kunishima N., Inohara N., Ishibashi Y., Ohta S., Morikawa K.;
RT   "Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-
RT   2 protein family.";
RL   J. Biol. Chem. 272:27886-27892(1997).
CC   -!- FUNCTION: Potent inhibitor of cell death. Inhibits activation of
CC       caspases. Appears to regulate cell death by blocking the voltage-
CC       dependent anion channel (VDAC) by binding to it and preventing the
CC       release of the caspase activator, CYC1, from the mitochondrial
CC       membrane. Also acts as a regulator of G2 checkpoint and progression to
CC       cytokinesis during mitosis.
CC   -!- FUNCTION: Isoform Bcl-X(L) also regulates presynaptic plasticity,
CC       including neurotransmitter release and recovery, number of axonal
CC       mitochondria as well as size and number of synaptic vesicle clusters.
CC       During synaptic stimulation, increases ATP availability from
CC       mitochondria through regulation of mitochondrial membrane ATP synthase
CC       F(1)F(0) activity and regulates endocytic vesicle retrieval in
CC       hippocampal neurons through association with DMN1L and stimulation of
CC       its GTPase activity in synaptic vesicles. May attenuate inflammation
CC       impairing NLRP1-inflammasome activation, hence CASP1 activation and
CC       IL1B release (By similarity). {ECO:0000250|UniProtKB:Q07817,
CC       ECO:0000269|PubMed:18250306, ECO:0000269|PubMed:21926988,
CC       ECO:0000269|PubMed:23792689, ECO:0000269|PubMed:7828536,
CC       ECO:0000269|PubMed:8662675}.
CC   -!- FUNCTION: Isoform Bcl-X(S) promotes apoptosis.
CC   -!- SUBUNIT: Homodimer. Interacts with BCL2L11 (By similarity). Interacts
CC       with BAD. Interacts with PGAM5. Interacts with HEBP2. Interacts with
CC       p53/TP53 and BBC3; interaction with BBC3 disrupts the interaction with
CC       p53/TP53. Interacts with ATP5F1A and ATP5F1B; the interactions mediate
CC       the association of isoform Bcl-X(L) with the mitochondrial membrane ATP
CC       synthase F(1)F(0) ATP synthase (PubMed:21926988). Interacts with VDAC1
CC       (By similarity). Interacts with BCL2L11 (via BH3) (By similarity).
CC       Interacts with RNF183 (By similarity). Interacts with GIMAP3/IAN4 and
CC       GIMAP5/IAN5 (By similarity). Interacts with GIMAP5 and HSPA8/HSC70; the
CC       interaction between HSPA8 and BCL2L1 is impaired in the absence of
CC       GIMAP5 (By similarity). Interacts with isoform 4 of CLU; this
CC       interaction releases and activates BAX and promotes cell death (By
CC       similarity). {ECO:0000250|UniProtKB:Q07817,
CC       ECO:0000250|UniProtKB:Q64373, ECO:0000269|PubMed:21926988}.
CC   -!- SUBUNIT: [Isoform Bcl-X(L)]: Forms heterodimers with BAX, BAK or BCL2;
CC       heterodimerization with BAX does not seem to be required for anti-
CC       apoptotic activity (By similarity). Interacts with isoform 1 of SIVA1;
CC       the interaction inhibits the anti-apoptotic activity (By similarity).
CC       Interacts with IKZF3 (By similarity). Interacts with RTL10/BOP (By
CC       similarity). Interacts with DNM1L and CLTA; DNM1L and BCL2L1 isoform
CC       BCL-X(L) may form a complex in synaptic vesicles that also contains
CC       clathrin and MFF (PubMed:18250306, PubMed:23792689). Interacts (via the
CC       loop between motifs BH4 and BH3) with NLRP1 (via LRR repeats), but not
CC       with NLRP2, NLRP3, NLRP4, PYCARD, nor MEFV (By similarity). Interacts
CC       with BECN1 (By similarity). {ECO:0000250|UniProtKB:Q07817,
CC       ECO:0000269|PubMed:18250306, ECO:0000269|PubMed:23792689}.
CC   -!- INTERACTION:
CC       P53563-1; P08081: Clta; NbExp=2; IntAct=EBI-287204, EBI-916140;
CC       P53563-1; O35303: Dnm1l; NbExp=4; IntAct=EBI-287204, EBI-1767447;
CC   -!- SUBCELLULAR LOCATION: [Isoform Bcl-X(L)]: Mitochondrion inner membrane.
CC       Mitochondrion outer membrane. Mitochondrion matrix. Cytoplasmic
CC       vesicle, secretory vesicle, synaptic vesicle membrane. Cytoplasm,
CC       cytosol. Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome {ECO:0000250}. Nucleus membrane {ECO:0000250}; Single-pass
CC       membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}.
CC       Note=Localizes to the centrosome when phosphorylated at Ser-49 (By
CC       similarity). After neuronal stimulation, translocates from cytosol to
CC       synaptic vesicle and mitochondrion membrane in a calmodulin-dependent
CC       manner. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Bcl-X(L); Synonyms=Bcl-xL;
CC         IsoId=P53563-1; Sequence=Displayed;
CC       Name=Bcl-X(S); Synonyms=Bcl-xS;
CC         IsoId=P53563-2; Sequence=VSP_000520;
CC       Name=Bcl-X(beta);
CC         IsoId=P53563-3; Sequence=VSP_000521;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues. Bcl-X(beta) is
CC       specifically expressed in cerebellum, heart, and thymus. In the ovary,
CC       the predominant form is Bcl-X(L), with a small but detectable level of
CC       Bcl-X(S).
CC   -!- DOMAIN: The BH4 motif is required for anti-apoptotic activity. The BH1
CC       and BH2 motifs are required for both heterodimerization with other Bcl-
CC       2 family members and for repression of cell death.
CC   -!- DOMAIN: The loop between motifs BH4 and BH3 is required for the
CC       interaction with NLRP1. {ECO:0000250|UniProtKB:Q07817}.
CC   -!- PTM: Proteolytically cleaved by caspases during apoptosis. The cleaved
CC       protein, lacking the BH4 motif, has pro-apoptotic activity (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on Ser-62 by CDK1. This phosphorylation is partial
CC       in normal mitotic cells, but complete in G2-arrested cells upon DNA-
CC       damage, thus promoting subsequent apoptosis probably by triggering
CC       caspases-mediated proteolysis. Phosphorylated by PLK3, leading to
CC       regulate the G2 checkpoint and progression to cytokinesis during
CC       mitosis. Phosphorylation at Ser-49 appears during the S phase and G2,
CC       disappears rapidly in early mitosis during prometaphase, metaphase and
CC       early anaphase, and re-appears during telophase and cytokinesis (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by RNF183 during prolonged ER stress, leading to
CC       degradation by the proteosome. {ECO:0000250|UniProtKB:Q07817}.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC60701.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAC60702.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X82537; CAA57886.1; -; Genomic_DNA.
DR   EMBL; X82537; CAA57887.1; -; Genomic_DNA.
DR   EMBL; U10579; AAA19257.1; -; Unassigned_DNA.
DR   EMBL; U72350; AAB17353.1; -; mRNA.
DR   EMBL; U72349; AAB17352.1; -; mRNA.
DR   EMBL; U34963; AAA77686.1; -; mRNA.
DR   EMBL; S76513; AAC60701.2; ALT_INIT; mRNA.
DR   EMBL; S78284; AAC60702.1; ALT_INIT; mRNA.
DR   EMBL; BC094213; AAH94213.1; -; mRNA.
DR   PIR; I67431; I67431.
DR   PIR; I67435; I67435.
DR   PIR; S51761; S51761.
DR   RefSeq; NP_001028842.1; NM_001033670.1. [P53563-1]
DR   RefSeq; NP_001028843.1; NM_001033671.1. [P53563-2]
DR   RefSeq; NP_113723.2; NM_031535.2.
DR   RefSeq; XP_006235327.1; XM_006235265.3. [P53563-1]
DR   PDB; 1AF3; X-ray; 2.50 A; A=1-196.
DR   PDB; 4QNQ; X-ray; 2.30 A; A/B/C/D/E/F/G/H/I/J/K/L=1-233.
DR   PDBsum; 1AF3; -.
DR   PDBsum; 4QNQ; -.
DR   AlphaFoldDB; P53563; -.
DR   BMRB; P53563; -.
DR   SMR; P53563; -.
DR   BioGRID; 246998; 5.
DR   ComplexPortal; CPX-2022; BAD:BCL-XL complex. [P53563-1]
DR   ComplexPortal; CPX-2026; BIM:BCL-XL complex. [P53563-1]
DR   ComplexPortal; CPX-2030; PUMA:BCL-XL complex. [P53563-1]
DR   ComplexPortal; CPX-2038; BID:BCL-XL complex. [P53563-1]
DR   ComplexPortal; CPX-300; BCL-XL complex. [P53563-1]
DR   CORUM; P53563; -.
DR   DIP; DIP-29698N; -.
DR   IntAct; P53563; 5.
DR   STRING; 10116.ENSRNOP00000069758; -.
DR   ChEMBL; CHEMBL1075182; -.
DR   iPTMnet; P53563; -.
DR   PhosphoSitePlus; P53563; -.
DR   SwissPalm; P53563; -.
DR   jPOST; P53563; -.
DR   PaxDb; 10116-ENSRNOP00000043542; -.
DR   Ensembl; ENSRNOT00000010762.8; ENSRNOP00000010762.4; ENSRNOG00000007946.8. [P53563-1]
DR   GeneID; 24888; -.
DR   KEGG; rno:24888; -.
DR   UCSC; RGD:2200; rat. [P53563-1]
DR   AGR; RGD:2200; -.
DR   CTD; 598; -.
DR   RGD; 2200; Bcl2l1.
DR   eggNOG; KOG4728; Eukaryota.
DR   GeneTree; ENSGT01120000271857; -.
DR   HOGENOM; CLU_085401_0_1_1; -.
DR   InParanoid; P53563; -.
DR   OMA; RIIEWMT; -.
DR   OrthoDB; 4028889at2759; -.
DR   PhylomeDB; P53563; -.
DR   Reactome; R-RNO-111453; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members.
DR   Reactome; R-RNO-844455; The NLRP1 inflammasome.
DR   Reactome; R-RNO-9648002; RAS processing.
DR   EvolutionaryTrace; P53563; -.
DR   PRO; PR:P53563; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000007946; Expressed in thymus and 19 other cell types or tissues.
DR   ExpressionAtlas; P53563; baseline and differential.
DR   GO; GO:0097136; C:Bcl-2 family protein complex; ISO:ComplexPortal.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0031966; C:mitochondrial membrane; ISO:RGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098793; C:presynapse; IDA:CAFA.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:SynGO.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0051400; F:BH domain binding; IPI:RGD.
DR   GO; GO:0051434; F:BH3 domain binding; ISO:RGD.
DR   GO; GO:0030276; F:clathrin binding; IPI:CAFA.
DR   GO; GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IDA:RGD.
DR   GO; GO:0051020; F:GTPase binding; IPI:CAFA.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0097371; F:MDM2/MDM4 family protein binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0071839; P:apoptotic process in bone marrow cell; ISO:RGD.
DR   GO; GO:0071312; P:cellular response to alkaloid; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; ISO:RGD.
DR   GO; GO:1905218; P:cellular response to astaxanthin; IEP:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0036018; P:cellular response to erythropoietin; IEP:RGD.
DR   GO; GO:0071480; P:cellular response to gamma radiation; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IEP:RGD.
DR   GO; GO:1990646; P:cellular response to prolactin; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0097048; P:dendritic cell apoptotic process; ISO:RGD.
DR   GO; GO:0044565; P:dendritic cell proliferation; ISO:RGD.
DR   GO; GO:0035234; P:ectopic germ cell programmed cell death; ISO:RGD.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0009566; P:fertilization; ISO:RGD.
DR   GO; GO:0007281; P:germ cell development; ISO:RGD.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:RGD.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; ISO:RGD.
DR   GO; GO:0051093; P:negative regulation of developmental process; ISO:RGD.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:1900118; P:negative regulation of execution phase of apoptosis; ISS:UniProtKB.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:1902230; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage; ISO:RGD.
DR   GO; GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; ISO:ComplexPortal.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; ISO:ComplexPortal.
DR   GO; GO:2000242; P:negative regulation of reproductive process; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001171; P:positive regulation of ATP biosynthetic process; IMP:CAFA.
DR   GO; GO:0032946; P:positive regulation of mononuclear cell proliferation; ISO:RGD.
DR   GO; GO:2000809; P:positive regulation of synaptic vesicle clustering; IMP:CAFA.
DR   GO; GO:1900244; P:positive regulation of synaptic vesicle endocytosis; IMP:CAFA.
DR   GO; GO:2000302; P:positive regulation of synaptic vesicle exocytosis; IMP:CAFA.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0032465; P:regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; ISO:RGD.
DR   GO; GO:1900452; P:regulation of long-term synaptic depression; IMP:CAFA.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; ISO:RGD.
DR   GO; GO:0051881; P:regulation of mitochondrial membrane potential; ISO:RGD.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; IDA:SynGO.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; ISO:RGD.
DR   GO; GO:0046898; P:response to cycloheximide; ISO:RGD.
DR   GO; GO:0034097; P:response to cytokine; ISO:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IEP:RGD.
DR   GO; GO:0036017; P:response to erythropoietin; IEP:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IDA:RGD.
DR   GO; GO:0010288; P:response to lead ion; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0009314; P:response to radiation; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0036466; P:synaptic vesicle recycling via endosome; IMP:CAFA.
DR   CDD; cd06845; Bcl-2_like; 1.
DR   DisProt; DP00449; -.
DR   Gene3D; 1.10.437.10; Blc2-like; 1.
DR   InterPro; IPR013279; Apop_reg_BclX.
DR   InterPro; IPR036834; Bcl-2-like_sf.
DR   InterPro; IPR046371; Bcl-2_BH1-3.
DR   InterPro; IPR026298; Bcl-2_fam.
DR   InterPro; IPR002475; Bcl2-like.
DR   InterPro; IPR004725; Bcl2/BclX.
DR   InterPro; IPR020717; Bcl2_BH1_motif_CS.
DR   InterPro; IPR020726; Bcl2_BH2_motif_CS.
DR   InterPro; IPR020728; Bcl2_BH3_motif_CS.
DR   InterPro; IPR003093; Bcl2_BH4.
DR   InterPro; IPR020731; Bcl2_BH4_motif_CS.
DR   NCBIfam; TIGR00865; bcl-2; 1.
DR   PANTHER; PTHR11256; BCL-2 RELATED; 1.
DR   PANTHER; PTHR11256:SF12; BCL-2-LIKE PROTEIN 1; 1.
DR   Pfam; PF00452; Bcl-2; 1.
DR   Pfam; PF02180; BH4; 1.
DR   PRINTS; PR01864; APOPREGBCLX.
DR   PRINTS; PR01862; BCL2FAMILY.
DR   SMART; SM00337; BCL; 1.
DR   SMART; SM00265; BH4; 1.
DR   SUPFAM; SSF56854; Bcl-2 inhibitors of programmed cell death; 1.
DR   PROSITE; PS50062; BCL2_FAMILY; 1.
DR   PROSITE; PS01080; BH1; 1.
DR   PROSITE; PS01258; BH2; 1.
DR   PROSITE; PS01259; BH3; 1.
DR   PROSITE; PS01260; BH4_1; 1.
DR   PROSITE; PS50063; BH4_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Endocytosis; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Mitochondrion outer membrane; Nucleus;
KW   Phosphoprotein; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..233
FT                   /note="Bcl-2-like protein 1"
FT                   /id="PRO_0000143065"
FT   TRANSMEM        210..226
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          27..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           4..24
FT                   /note="BH4"
FT   MOTIF           86..100
FT                   /note="BH3"
FT   MOTIF           129..148
FT                   /note="BH1"
FT   MOTIF           180..195
FT                   /note="BH2"
FT   COMPBIAS        32..46
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         49
FT                   /note="Phosphoserine; by PLK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q07817"
FT   MOD_RES         62
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q07817"
FT   VAR_SEQ         126..188
FT                   /note="Missing (in isoform Bcl-X(S))"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000520"
FT   VAR_SEQ         189..233
FT                   /note="DTFVDLYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK -> VRT
FT                   TPLVCPPLVCLSSVEIPNCPFWSPGMVVEDIDYSGDIPGLL (in isoform Bcl-
FT                   X(beta))"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_000521"
FT   CONFLICT        6
FT                   /note="R -> Q (in Ref. 1; CAA57886/CAA57887)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        12
FT                   /note="F -> S (in Ref. 2; AAA19257)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        64
FT                   /note="A -> E (in Ref. 2; AAA19257)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        81
FT                   /note="I -> L (in Ref. 4; AAA77686/AAC60701/AAC60702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        119
FT                   /note="A -> V (in Ref. 4; AAA77686/AAC60701/AAC60702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143..144
FT                   /note="FF -> SS (in Ref. 4; AAA77686/AAC60701)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="A -> T (in Ref. 4; AAA77686/AAC60701/AAC60702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="A -> P (in Ref. 4; AAA77686/AAC60701/AAC60702)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..19
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   TURN            25..28
FT                   /evidence="ECO:0007829|PDB:1AF3"
FT   HELIX           82..100
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   HELIX           102..111
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   TURN            116..118
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   HELIX           119..130
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   TURN            131..133
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   HELIX           137..156
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   HELIX           162..177
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   HELIX           179..184
FT                   /evidence="ECO:0007829|PDB:4QNQ"
FT   HELIX           187..196
FT                   /evidence="ECO:0007829|PDB:4QNQ"
SQ   SEQUENCE   233 AA;  26158 MW;  2B62B6C63864BC8F CRC64;
     MSQSNRELVV DFLSYKLSQK GYSWSQFSDV EENRTEAPEE TEPERETPSA INGNPSWHLA
     DSPAVNGATG HSSSLDAREV IPMAAVKQAL REAGDEFELR YRRAFSDLTS QLHITPGTAY
     QSFEQVVNEL FRDGVNWGRI VAFFSFGGAL CVESVDKEMQ VLVSRIASWM ATYLNDHLEP
     WIQENGGWDT FVDLYGNNAA AESRKGQERF NRWFLTGMTV AGVVLLGSLF SRK
//
